SprouleBBustoUSomerG. Characteristics of dependent and nondependent regular users of codeine. J Clin Psychopharmacol1999;19:367-72.
3.
BrandsBBlakeJSprouleB. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend2004;73:199-207.
4.
SprouleBBrandsBLiS. Changing patterns in opioid addiction. Can Fam Physician2009;55:68-69.e5.
5.
YangJZlomislicD.Star investigation: Canada’s invisible codeine problem. The Toronto Star. Jan. 17, 2015. Available: www.thestar.com.
6.
OrriolsLGaillardJLapeyre-MestreM. Evaluation of abuse and dependence on drugs used for self-medication. Drug Saf2009;32(10):859-73.
7.
FreiMNielsenSDobbinM. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust2010;193(5):294-6.
8.
McAvoyBDobbinMTobinC.Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J2011;124(1346):29-34.
9.
TobinCDobbinMMcAvoyB.Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom. Aust N Z J Public Health2013;37(5):483-8.
10.
RobinsonGRobinsonSMcCarthyP. Misuse of over-the-counter codeine-containing analgesics: dependence and other adverse effects. N Z Med J2010;123(1317):59-65.
11.
RoxburghAHallWBurnsL. Trends and characteristics of accidental and intentional codeine overdose deaths in Australia. Med J Aust2015;203(7):299.
12.
GomesTJuurlinkDYaoZ. Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. CMAJ Open2014;2(4):E256-61.
13.
ClarkTEadieJKnueP. Prescription drug monitoring programs: an assessment of the evidence for best practices. Waltham (MA): Heller School for Social Policy and Management, Brandeis University; 2012.
14.
SprouleB.Prescription monitoring programs in Canada: best practice and program review. Ottawa (ON): Canadian Centre on Substance Abuse; 2015.
Saskatchewan College of Pharmacists. Policy statement: control over the sales of exempted codeine products. Apr. 62010. Available: www.saskpharm.ca/site/manual?nav=03 (accessed Oct. 2, 2015).
17.
Governement of New Brunswick. Drug information system and prescription monitoring program. Available: www2.gnb.ca (accessed May 30, 2016).
Health Canada, Health Products and Food Branch. Guidance document: determining prescription status for human and veterinary drugs. 2013. Available: www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/index-eng.php (accessed Jun. 22, 2015).
21.
BoakAHamiltonHAdlafE. Drug use among Ontario students, 1977-2013: detailed OSDUHS findings (CAMH Research Document Series No. 36). Toronto (ON): Centre for Addiction and Mental Health; 2013.
22.
De CraenADi GiulioGLampe-SchoenmaeckersA. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. BMJ1996;313(7053):321-5.
23.
SmithLMooreRMcQuayH. Using evidence from different sources: an example using paracetamol 1000 mg plus codeine 60 mg. BMC Med Res Methodol2001;1:1.
24.
MooreRDerrySMcquayH. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev2011;(9):CD008659.
25.
MitchellAvan ZantenSInglisK. A randomized controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine after outpatient general surgery. J Am Coll Surg2008;206(3): 472-9.
26.
DanielsSGoulderMAspleyS. A randomised, five-parallel-group, placebo-controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single-tablet combination of ibuprofen/paracetamol for postoperative dental pain. Pain2011;152(3):632-42.
27.
NautaMLandsmeerMKorenG.Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg2009;198(2):256-61.
28.
SmithSSchroederKFaheyT.Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev2012;(8):CD001831.